1-3 of 3
Joanne Lager
Close
Sort by
Journal Articles

TIG-007: Study of EOS884448/GSK4428859A Alone, and in Combination with Iberdomide with or without Dexamethasone, in Participants with Relapsed or Refractory Multiple Myeloma

Philippe Moreau, Leona Holmberg, Nathalie Meuleman, Philippa Graham, Olivier De Henau, Gregory Driessens, Yvonne McGrath, Joanne Lager, Geoffrey R Hill
Journal: Blood
Blood (2021) 138 (Supplement 1): 2745.
https://doi.org/10.1182/blood-2021-152395
Published: 2021
Journal Articles

Phase I Trial of SAR245408 (S08), a Pan-Phosphatidylinositol 3 Kinase (PI3K) Inhibitor, in Patients with Chronic Lymphocytic Leukemia (CLL) and Lymphoma

Jennifer R Brown, MD, PhD, Matthew S. Davids, MD, Jordi Rodon, MD, Pau Abrisqueta, MD, Arthur P. DeCillis, MD, MS, Kevin Rockich, Coumaran Egile, Adrianne Kelly, MD, Yi Xu, Joanne Lager, MD, Farrukh T Awan, MD, MS
Journal: Blood
Blood (2011) 118 (21): 2683.
https://doi.org/10.1182/blood.V118.21.2683.2683
Published: 2011
Journal Articles

A Phase I Dose Expansion Cohort Study of the Safety, Pharmacokinetics and Pharmacodynamics of SAR245409 (S09), An Orally Administered PI3K/mTOR Inhibitor, in Patients with Lymphoma

Kyriakos P Papadopoulos, MD, Pau Abrisqueta, MD, Glenda Chambers, BSN, RN, OCN, CCRC, Drew Rasco, MD, Amita Patnaik, Josep Tabernero, MD, Kanya Rajangam, MD, PhD, Kevin Rockich, Coumaran Egile, Adrianne Kelly, MD, Yi Xu, Joanne Lager, MD, Julie M Vose, MD
Journal: Blood
Blood (2011) 118 (21): 1608.
https://doi.org/10.1182/blood.V118.21.1608.1608
Published: 2011